王慧瑋

分析條件 ......................................................... 1
薄層層析法(TLC) .............................................. 1
氣相層析質譜儀(GC-MS) ...................................... 4
液相層析串聯質譜儀(LC-MS/MS) .............................. 5
Bisacodyl ........................................................ 7
Desacetyl bisacodyl ..........................................15
Cetilistat ........................................................23
Clobenzorex ....................................................31
Diethylpropion ..................................................39
2-Diphenylmethylpyrrolidine ....................................47
Fenfluramine ....................................................55
Fluoxetine .......................................................63
Lorcaserin.......................................................71
Mazindol ........................................................79
Mephentermine .................................................87
Methamphetamine ..............................................95
Orlistat ..........................................................103
Phenolphthalein ................................................111
Phentermine ....................................................119
Phenylpropanolamine ..........................................127
Rimonabant .....................................................135
Sibutramine .....................................................143
N-Desmethylsibutramine .....................................151
N-Didesmethylsibutramine ...................................159
總表 .............................................................167

分析條件 ......................................................... 1
薄層層析法(TLC) .............................................. 1
氣相層析質譜儀(GC-MS) ...................................... 4
液相層析串聯質譜儀(LC-MS/MS) .............................. 5
Bisacodyl ........................................................ 7
Desacetyl bisacodyl ..........................................15
Cetilistat ........................................................23
Clobenzorex ............................